APPLIED DNA SCIENCES INCAPDN
| Sep 30,
2011 | Sep 30,
2016 | Sep 30,
2019 | Sep 30,
2020 | Sep 30,
2021 | Sep 30,
2022 |
|---|
| Net loss | - | - | -8,632,446 | -13,028,904 | -14,278,439 | -8,270,059 |
|---|
| Depreciation and amortization | 367,556 | - | 390,424 | 285,730 | 844,438 | 1 |
|---|
| Loss on disposal of property and equipment | - | - | - | - | -208,782 | - |
|---|
| Goodwill and Intangible Asset Impairment | - | - | - | - | 821,741 | - |
|---|
| Loss on extinguishment of convertible notes payable | - | - | -1,260,399 | - | -1,774,662 | - |
|---|
| Gain on extinguishment of notes payable | - | - | - | - | 839,945 | - |
|---|
| Public offering costs incurred | - | - | - | - | - | 2 |
|---|
| Loss on issuance of warrants | - | - | - | - | - | 11 |
|---|
| Fair Value Adjustment of Warrants | - | - | - | - | - | -17,999,521 |
|---|
| Stock-based compensation | 1 | - | 1 | 1 | 2 | 3 |
|---|
| Provision for bad debts | - | - | 7,624 | 45,280 | 28,629 | 269,451 |
|---|
| Accounts receivable | 145,558 | - | -638,339 | -600,352 | 3 | 532,957 |
|---|
| Inventories | - | - | -78,740 | 354,738 | 872,566 | -767,689 |
|---|
| Prepaid expenses and other current assets and deposits | -70,030 | - | -23,767 | 27,288 | -30,415 | 493,220 |
|---|
| Accounts payable and accrued liabilities | -199,490 | - | 667,898 | 427,365 | 94,711 | 930,497 |
|---|
| Deferred revenue | - | - | -727,920 | -117,957 | -230,036 | 282,557 |
|---|
| Net cash used in operating activities | - | - | -6,861,772 | -11,143,059 | -13,387,955 | -8,976,706 |
|---|
| Purchase of property and equipment | 89,108 | - | 67,438 | 1 | 3 | 489,553 |
|---|
| Net cash used in investing activities | - | - | -67,438 | -1,063,698 | -2,548,695 | -489,553 |
|---|
| Proceeds from Warrant Exercises | - | - | - | 8 | 3 | 4 |
|---|
| Net Proceeds From Sale Of Common Stock And Warrants | - | - | 2 | 11 | - | 14 |
|---|
| Repayment of convertible notes | - | - | - | - | 2 | - |
|---|
| Net cash provided by financing activities | - | - | 6 | 19 | 15 | 18 |
|---|
| Net increase (decrease) in cash and cash equivalents | - | - | -1,100,576 | 7 | -1,231,795 | 9 |
|---|
| Cash paid during period for interest | - | - | - | 45,354 | - | - |
|---|
| Income Taxes Paid | - | - | - | - | - | - |
|---|
| Interest paid in kind | - | - | 126,980 | 35,625 | 28,329 | - |
|---|
| Deemed dividend warrant modifications | - | - | - | - | - | 110,105 |
|---|
| Property and equipment acquired, and included in accounts payable | - | - | - | 144,025 | 181,807 | - |
|---|
| Issuance of stock options for payment of accrued bonus | - | - | - | - | - | 300,000 |
|---|
| Issuance of warrants in settlement of convertible notes payable | - | - | - | - | 1 | - |
|---|
| Fair value of warrants exercised | - | - | - | - | - | 3 |
|---|
| Fair value of warrants issued | - | - | - | - | - | 26 |
|---|